Gene mutation may provide novel drug targets for rare kidney and liver disease
An international study team have investigated how mutations in the PKHD1 gene are associated with autosomal recessive polycystic kidney disease. These findings may help in the development of future treatment strategies.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.